Similarly, we looked at the relationship between CELSR3 and immunoassays and discovered that LAG3, CTLA4, CD274, HAVCR2, TIGIT, and SIGLEC15 were increased in WHO grade II HNSCC compared to WHO grade I HNSCC. This evidence concerns the gene HAVCR2 and head and neck squamous cell carcinoma.